SlideShare ist ein Scribd-Unternehmen logo
1 von 33
DRUG DISTRIBUTION
Presented by
Mr. Naresh Gorantla, M.Pharm.., (Ph.D)
Assoc professor,
Balaji college of Pharmacy,Anantapuramu.
nareshgorantlauk@gmail.com
 Once a drug enter in to the blood stream, the drug is
subjected to a number of processes called as Disposition
Processes that tend to lower the plasma concentration.
DRUG DISTRIBUTION
2. Elimination which involves irreversible loss of drug
from the body.
 It comprises of biotransformation and excretion.
1. Distribution: Reversible transfer of drugs between
one compartment and another ( between blood &
extravascular fluids & tissues)
 Drug Distribution is the Reversible transfer of drug between
one compartment (blood) to another (extra vascular tissue).
 Distribution is predominantly a passive process - The driving
force is the concentration gradient between the blood and
extravascular tissues.
 Process occurs by the diffusion of free drug until equilibrium
is established.
Significance :-
Pharmacological action of drug depends upon its
concentration at the site of action.
Thus distribution plays important role in
 Onset of Action
 Intensity of Action
 Duration of Action
Steps in drug distribution
 Permeation of free or unbound drug into interstitial
/ extracellular fluid
 Permeation of drug present in extracellular fluid into
intracellular fluid (rate limiting step).
FACTORS AFFECTING DISTRIBUTION OF DRUGS
1. Tissue Permeability of Drugs
 Physicochemical Properties of drug like
Mol.size, pKa, o/w Partition Coefficient
 Physiological barriers to diffusion of drugs
2. Organ/tissue size and perfusion rate
3. Binding of drugs to tissue components.
 binding of drug to blood components
 binding of drug to extra cellular components
4. Miscellaneous
TISSUE PERMEABILITY OF DRUGS
1. Physicochemical Properties of drug
⚫ Molecular size,
⚫ pKa
⚫ o/w Partition coefficient.
2. Physiological barriers to Diffusion of Drugs
⚫ Simple Capillary Endothelial Barrier
⚫ Simple Cell Membrane Barrier
⚫ Blood Brain Barrier
⚫ Blood – CSF Barrier
⚫ Blood Placental Barrier
⚫ Blood Testis Barrier
1. TISSUE PERMEABILITY OF DRUG
a. physicochemical properties:
i) Molecular Size:
 Mol wt less then 500 to 600 Dalton easily pass capillary
membrane to extra cellular fluid.
 Penetration of drug from ECF to cells is function of Mol size,
ionization constant & lipophilicity of drug.
 From extra cellular fluid to cross cell membrane through aqueous
filled channels need particle size less then 50 Dalton (small) with
hydrophilic property.
 Large mol size restricted or require specialized transport system.
1. TISSUE PERMEABILITY OF DRUG
a. Physicochemical Properties:
ii) Degree of Ionization (pKa)
The pH at which half of a drug is unionized is called pKa
 A weak acid becomes unionized in a strong acidic environment. A
weak acid becomes ionized in a neutral or basic environment.
&
 A weak base becomes unionized in a strong basic environment. A weak
base becomes ionized in a neutral or acidic environment.
BUT
The PH of Blood plasma, extra cellular fluid and CSF is 7.4( constant)
All the drugs ionize at plasma pH (i.e. Polar , Hydrophilic Drugs)
Can not penetrate the Lipoidal cell membrane.
1. TISSUE PERMEABILITY OF DRUG
a. Physicochemical Properties:
iii) o/w permiability:
 Polar and hydrophilic drugs are less likely to cross the cell
membrane.
Where,,,,,,,,
 Nonpolar and hydrophobic drugs are more likely to cross the cell membrane
EFFECTIVE KO/W = Fraction unionized
at pH 7.4
x KO/W of unionized
drug
In case of polar drugs where permeability is the rate- limiting
step in the distribution , the driving force is the effective
partition coefficient of drug ……..that can be calculated by
above formula
 Lipoidal drug penetrate the tissue rapidly. Among Drugs
with same Ko/w but diff in ionization of blood pH.
 One which has less ionization show better distribution.
E.g. Phenobarbital > salicylic acid
Both are having same Ko/w but phenobarbitol have
more unionized at blood pH.
 highly specialized and less permeable to water soluble
drugs.
B. PHYSIOLOGICAL BARRIERS
1) The simple capillary endothelial barrier
 Capillary supply the blood to the most inner tissue
 All drugs ionized or unionized molecular size less than 600 dalton
diffuse through the capillary endothelium to interstitial fluid.
 Only drugs that bound to that blood components can’t pass through
this barrier Because of larger size of complex.
2. Simple cell membrane barrier:
 Once the drug diffuse through capillary to extracellular
fluid ,its further entry in to cells of most tissue is limited.
 Simple cell Membrane is similar to the lipoidal barrier
(absorption).
 Non polar & hydrophillic drugs will passes through it
(passively).
 Lipophilic drugs with 50-600 dalton mol size &
 Hydrophilic, Polar drugs with ‹50dalton will pass this
membrane.
3) Blood brain barrier
3) Blood brain barrier
 Capillary in brain is highly specialized & much less
permeable to water soluble drugs.
 ENDOTHELIAL CELLS :- Tightly bonded with each other by
intracellular junctions.
 ASTROCYTES :- present @ the base of endothelial tissue
and act as supporting materials & it Form Envelop around the
capillary thus intercellular passage get blocked.
 BBB is lipoidal barrier, thus drugs with high o/w partition
coefficient diffuse passively others (moderately lipid soluble
and partially ionised molecules) passes slowly.
 Polar natural substance (sugar & amino acid) transported
to brain actively thus structurally similar drug can pass easily
to BBB.
Only lipid soluble non ionised drugs
penetrate easily to brain
• e.g. volatile anaesthetics, ultra short acting
barbiturates, narcotic analgesic, dopamine
precursors and sympathomimetics
Water soluble ionised drug fail to
penetrate BBB.
• e.g. dopamine, serotonine, streptomycin,
quaternary substances
4. Blood CSF barrier
 Mainly formed by choroid
plexus of lateral, third &
fourth ventricle.
 The capillary endothelium
that line choroid plexus have
open junctions however the
choroid cells are joined to each
other by tight junctions.
 Only highly lipid soluble,
unionized drugs can pass
through it.
Blood cerebrospinal fluid barrier:
 But CSF-brain barrier is not connected with tight junction.
 Extremely permeable to drug molecule
Clinical significance - Penicillin being less lipid soluble
has poor penetration through BBB but if given by
intrathecal route and thus cross CSF-brain barrier to
treat the condition like brain abscess.
 Maternal & fetal blood vessels
are separated by a
number of tissue layers made
of fetal trophoblast , basement
membrane & endothelium -
placental barrier.
 Drugs having molecular size
less than 1000 D and
moderate lipid solubility cross
the placental barrier
(Sulfonamides, Barbiturets,
Steroids, Narcotic some
Antibiotics ) .
5. Blood placental barrier
 Transfer of substances -
Passive diffusion – Non polar lipid soluble substances.
Active transport - Amino acids and glucose.
Pinocytosis - Maternal immunoglobulins.
 Drugs that can cross Blood-Placental barrier.
Ethanol, sulfonamides, barbiturates, gaseous
anesthetics, steroids, narcotics, anticonvulsants etc.
 Teratogen -Agent that causes toxic effect on fetus.
 Teratogenicity –
Fetal abnormality caused by administration of drugs
during pregnancy.
 Drug administered in last trimester affect
vital functions of fetus.
 Morphine - Fetal asphyxia
 Antithyroid drugs - Neonatal goitre Hypoxia
increase placental permeability for drugs.
 Fetus to some extend is exposed to all drugs taken
by mother hence drug administration should be
severly restricted in pregnancy.
6. Blood testis barrier
 Located at the sertoli-
sertoli cell junction.
 Tight junction between
neighboring sertoli cells
that act as barrier.
 Restrict the passage of
drugs to spermatocyte and
spermatids.
2. Organ /tissue size &perfusion rate
 Distribution is permeability related in following cases:
1. When the drug is ionic/polar/water soluble.
2. Where the highly selective physiology.
barrier restrict the diffusion of such drugs to the inside of cell.
 Distribution will be perfusion rate limited
1. When the drug is highly lipophilic.
2. When the membrane is highly permeable.
25
 Perfusion rate - It is defined as the volume of the blood
that flows per unit time per unit volume of the tissue.
Unit : ml/min/ml
 Highly perfused organs are -
Lungs > Kidneys > Adrenals > Liver > Heart >
Brain
3)Binding of drug to blood and other tissue components
• Binding of drugs to blood components
o Plasma proteins
o Blood cells
• Binding of drugs to extra vascular tissues
• Human serum albumin:-all types of drugs.
• ά1- acid glycoprotein: basic drugs like Imipramine.
• Lipoproteins :-basic, lipophilic drugs(chlorpromazin).
• ά1-Globuline :-steroids like corticosterone ,vit-B12.
• ά2-Globuline :-vit-A,D,E,K,cupric ions.
• Hemoglobin :-Phenytoin, phenothiazines.
i) Plasma protein binding
ii) Blood cells binding:-
RBC : 40% of blood comprise of blood cells, out of that 95%
cells are RBC.
 The RBC comprises of 3 components each of which can
bind to drugs:
 Hemoglobin
Carbonic Anhydrase
 Cell Membrane
 Drugs like, phenytoin, phenobarbiton binds with Hb.
 Imipramine, chlorpromazine binds with RBC Cell wall
B. Binding to Extra Vascular Tissue proteins:
• 40% of total body weight comprise of vascular tissues
• Tissue-drug binding result in localization of drug at specific
site in body and serve as reservoir.
• As binding increases it also increase bio-logical half
life.
• Irreversible binding leads to drug toxicity.
(carbamazepin-autoinduction)
• liver>kidney>lungs>muscle>skin>eye>bone>Hair, nail.
4). Miscellaneous Factors
 Age
a)Total body water
b)Fat content
c) Skeletal muscles
d)Organ composition
e) Plasma protein content
 Pregnancy
 Obesity
 Diet
 Disease states
a)AGE:-
Difference in distribution pattern is mainly due to
Total body water -(both ICF &ECF) greater in infants
Fat content - higher in infants & elderly
 Skeletal muscle - lesser in infants & elderly
organ composition – BBB is poorly developed in infants & myelin
content is low & cerebral blood flow is high, hence greater
penetration of drug in brain
 plasma protein content- low albumin in both infants & elderly
b) PREGNANCY:-
During Pregnancy, due to growth of UTERUS,PLECENTA,FETUS…
Increases the volume available for distribution drug.
 fetus have separate compartment for drug distribution, plasma & ECF
volume also increase but albumin content is low.
C) OBESITY :-
 In obese persons, high adipose (fatty acid) tissue so high distribution of
lipophilic drugs.
d) DIET:- A diet high in fats will increases free fatty acid levels in
circulation thereby affecting binding of acidic drugs (NSAIDs to
albumin).
e) DISEASE STATES:- mechanism involved in alteration of drug
distribution in disease states.
i) Altered albumin & other drug-binding protein concentration.
ii) Alteration or reduced perfusion to organ or tissue
iii) Altered tissue pH.
iv) Alteration of permeability of physiological barrier (BBB)
Ex- BBB(in meningitis & encephalities) BBBbecomes more permeable polar
antibiotics ampicilin, penicilin G. & patient affect CCF, Perfusion rate
to entire body decreases it affect distribution.
f) DRUG INTERACTION:-Displacement interaction occurs when
two drugs administered which having similar binding site affinity.
Ex. A.Warfarin (Displaced Drug)& B.Phenylbutabutazone (Displacer)HSA
Apparent Volume of Distribution
The apparent volume of distribution is a proportionality
constant relating the plasma concentration to the total amount of
drug in the body.
XαC
X=Vd.C
Vd=X/C
 Apparent volume of distribution is dependent on
concentration of drug in plasma.
 Drugs with a large apparent volume are more concentrated
in extra vascular tissues and less concentrated intravascular.
Vd =
Total amount of drug (mg/kg)
Concentration of drug in plasma (mg/l)
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Factors effecting on protein binding
Factors effecting on protein bindingFactors effecting on protein binding
Factors effecting on protein binding
Sai Vivek Kosaraju
 
Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugs
Zubia Arshad
 

Was ist angesagt? (20)

Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Distribution
DistributionDistribution
Distribution
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
 
Factors effecting on protein binding
Factors effecting on protein bindingFactors effecting on protein binding
Factors effecting on protein binding
 
Commonly used instrument in Experimental Pharmacology
Commonly used instrument in Experimental PharmacologyCommonly used instrument in Experimental Pharmacology
Commonly used instrument in Experimental Pharmacology
 
Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugs
 
Protein Drug Binding
Protein Drug BindingProtein Drug Binding
Protein Drug Binding
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administration
 
Drug absorption
Drug absorption Drug absorption
Drug absorption
 
Factors affecting metabolism of drug
Factors affecting metabolism of drugFactors affecting metabolism of drug
Factors affecting metabolism of drug
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugs
 
Factors affecting absorption of drugs
Factors affecting absorption of drugsFactors affecting absorption of drugs
Factors affecting absorption of drugs
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Excretion of drug
Excretion of drugExcretion of drug
Excretion of drug
 
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONBIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
 

Ähnlich wie Drug distribution

Ähnlich wie Drug distribution (20)

distribution of drugs
distribution of drugsdistribution of drugs
distribution of drugs
 
distribution.pdf
distribution.pdfdistribution.pdf
distribution.pdf
 
Drug Distribution
Drug DistributionDrug Distribution
Drug Distribution
 
Drug distribution and protein binding
Drug distribution and protein bindingDrug distribution and protein binding
Drug distribution and protein binding
 
Distribution.pptx
Distribution.pptxDistribution.pptx
Distribution.pptx
 
Drug distribution
Drug distribution Drug distribution
Drug distribution
 
Drug distribution
Drug distribution Drug distribution
Drug distribution
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugs
 
Distribution of Drugs and physiological barriers .pptx
Distribution of Drugs and physiological barriers .pptxDistribution of Drugs and physiological barriers .pptx
Distribution of Drugs and physiological barriers .pptx
 
Distribution of Drug
Distribution of DrugDistribution of Drug
Distribution of Drug
 
DISTRIBUTION OF DRUG
DISTRIBUTION OF DRUGDISTRIBUTION OF DRUG
DISTRIBUTION OF DRUG
 
HAMMAD RAZA MUSTAFAI
HAMMAD RAZA MUSTAFAIHAMMAD RAZA MUSTAFAI
HAMMAD RAZA MUSTAFAI
 
Umesh
UmeshUmesh
Umesh
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Distribution of drugs Pharmacokinetics
Distribution of drugs PharmacokineticsDistribution of drugs Pharmacokinetics
Distribution of drugs Pharmacokinetics
 
Drug distribution and factors affecting drug distribution
Drug distribution and factors affecting drug distributionDrug distribution and factors affecting drug distribution
Drug distribution and factors affecting drug distribution
 
Distribution of drugs final ppt
Distribution of drugs final pptDistribution of drugs final ppt
Distribution of drugs final ppt
 
Basics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptxBasics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptx
 
DISTRIBUTION OF DRUGS
DISTRIBUTION OF DRUGSDISTRIBUTION OF DRUGS
DISTRIBUTION OF DRUGS
 
Distribution.pptx
Distribution.pptxDistribution.pptx
Distribution.pptx
 

Mehr von Naresh Gorantla

Mehr von Naresh Gorantla (20)

Pharmaceutical packaging naresh
Pharmaceutical packaging nareshPharmaceutical packaging naresh
Pharmaceutical packaging naresh
 
Drug absorption naresh
Drug absorption   nareshDrug absorption   naresh
Drug absorption naresh
 
powders & granules
powders & granulespowders & granules
powders & granules
 
pharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_nareshpharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_naresh
 
Surgical Aids
Surgical AidsSurgical Aids
Surgical Aids
 
Extraction and galenicals
Extraction and galenicalsExtraction and galenicals
Extraction and galenicals
 
Semisolids
SemisolidsSemisolids
Semisolids
 
suppositories
suppositoriessuppositories
suppositories
 
2. emulsions and suspensions naresh
2. emulsions and suspensions   naresh2. emulsions and suspensions   naresh
2. emulsions and suspensions naresh
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
Penetration enhancers
Penetration enhancersPenetration enhancers
Penetration enhancers
 
Manufacturing of pharmaceutical dosage forms
Manufacturing of pharmaceutical dosage formsManufacturing of pharmaceutical dosage forms
Manufacturing of pharmaceutical dosage forms
 
Industrial hazards and safety
Industrial hazards and safetyIndustrial hazards and safety
Industrial hazards and safety
 
Family planning
Family planningFamily planning
Family planning
 
Herbomineral preparations
Herbomineral preparationsHerbomineral preparations
Herbomineral preparations
 
1. monophasic liquids naresh
1. monophasic liquids   naresh1. monophasic liquids   naresh
1. monophasic liquids naresh
 
Tablets
Tablets Tablets
Tablets
 
Capsules
CapsulesCapsules
Capsules
 
Parentrals
Parentrals Parentrals
Parentrals
 
Pharmaceutical Dosage forms
Pharmaceutical Dosage formsPharmaceutical Dosage forms
Pharmaceutical Dosage forms
 

Kürzlich hochgeladen

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Kürzlich hochgeladen (20)

Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

Drug distribution

  • 1. DRUG DISTRIBUTION Presented by Mr. Naresh Gorantla, M.Pharm.., (Ph.D) Assoc professor, Balaji college of Pharmacy,Anantapuramu. nareshgorantlauk@gmail.com
  • 2.  Once a drug enter in to the blood stream, the drug is subjected to a number of processes called as Disposition Processes that tend to lower the plasma concentration. DRUG DISTRIBUTION 2. Elimination which involves irreversible loss of drug from the body.  It comprises of biotransformation and excretion. 1. Distribution: Reversible transfer of drugs between one compartment and another ( between blood & extravascular fluids & tissues)
  • 3.  Drug Distribution is the Reversible transfer of drug between one compartment (blood) to another (extra vascular tissue).  Distribution is predominantly a passive process - The driving force is the concentration gradient between the blood and extravascular tissues.  Process occurs by the diffusion of free drug until equilibrium is established.
  • 4. Significance :- Pharmacological action of drug depends upon its concentration at the site of action. Thus distribution plays important role in  Onset of Action  Intensity of Action  Duration of Action
  • 5. Steps in drug distribution  Permeation of free or unbound drug into interstitial / extracellular fluid  Permeation of drug present in extracellular fluid into intracellular fluid (rate limiting step).
  • 6. FACTORS AFFECTING DISTRIBUTION OF DRUGS 1. Tissue Permeability of Drugs  Physicochemical Properties of drug like Mol.size, pKa, o/w Partition Coefficient  Physiological barriers to diffusion of drugs 2. Organ/tissue size and perfusion rate 3. Binding of drugs to tissue components.  binding of drug to blood components  binding of drug to extra cellular components 4. Miscellaneous
  • 7. TISSUE PERMEABILITY OF DRUGS 1. Physicochemical Properties of drug ⚫ Molecular size, ⚫ pKa ⚫ o/w Partition coefficient. 2. Physiological barriers to Diffusion of Drugs ⚫ Simple Capillary Endothelial Barrier ⚫ Simple Cell Membrane Barrier ⚫ Blood Brain Barrier ⚫ Blood – CSF Barrier ⚫ Blood Placental Barrier ⚫ Blood Testis Barrier
  • 8. 1. TISSUE PERMEABILITY OF DRUG a. physicochemical properties: i) Molecular Size:  Mol wt less then 500 to 600 Dalton easily pass capillary membrane to extra cellular fluid.  Penetration of drug from ECF to cells is function of Mol size, ionization constant & lipophilicity of drug.  From extra cellular fluid to cross cell membrane through aqueous filled channels need particle size less then 50 Dalton (small) with hydrophilic property.  Large mol size restricted or require specialized transport system.
  • 9. 1. TISSUE PERMEABILITY OF DRUG a. Physicochemical Properties: ii) Degree of Ionization (pKa) The pH at which half of a drug is unionized is called pKa  A weak acid becomes unionized in a strong acidic environment. A weak acid becomes ionized in a neutral or basic environment. &  A weak base becomes unionized in a strong basic environment. A weak base becomes ionized in a neutral or acidic environment. BUT The PH of Blood plasma, extra cellular fluid and CSF is 7.4( constant) All the drugs ionize at plasma pH (i.e. Polar , Hydrophilic Drugs) Can not penetrate the Lipoidal cell membrane.
  • 10. 1. TISSUE PERMEABILITY OF DRUG a. Physicochemical Properties: iii) o/w permiability:  Polar and hydrophilic drugs are less likely to cross the cell membrane. Where,,,,,,,,  Nonpolar and hydrophobic drugs are more likely to cross the cell membrane EFFECTIVE KO/W = Fraction unionized at pH 7.4 x KO/W of unionized drug In case of polar drugs where permeability is the rate- limiting step in the distribution , the driving force is the effective partition coefficient of drug ……..that can be calculated by above formula
  • 11.  Lipoidal drug penetrate the tissue rapidly. Among Drugs with same Ko/w but diff in ionization of blood pH.  One which has less ionization show better distribution. E.g. Phenobarbital > salicylic acid Both are having same Ko/w but phenobarbitol have more unionized at blood pH.  highly specialized and less permeable to water soluble drugs.
  • 12. B. PHYSIOLOGICAL BARRIERS 1) The simple capillary endothelial barrier  Capillary supply the blood to the most inner tissue  All drugs ionized or unionized molecular size less than 600 dalton diffuse through the capillary endothelium to interstitial fluid.  Only drugs that bound to that blood components can’t pass through this barrier Because of larger size of complex.
  • 13. 2. Simple cell membrane barrier:  Once the drug diffuse through capillary to extracellular fluid ,its further entry in to cells of most tissue is limited.  Simple cell Membrane is similar to the lipoidal barrier (absorption).  Non polar & hydrophillic drugs will passes through it (passively).  Lipophilic drugs with 50-600 dalton mol size &  Hydrophilic, Polar drugs with ‹50dalton will pass this membrane.
  • 14. 3) Blood brain barrier
  • 15. 3) Blood brain barrier  Capillary in brain is highly specialized & much less permeable to water soluble drugs.  ENDOTHELIAL CELLS :- Tightly bonded with each other by intracellular junctions.  ASTROCYTES :- present @ the base of endothelial tissue and act as supporting materials & it Form Envelop around the capillary thus intercellular passage get blocked.  BBB is lipoidal barrier, thus drugs with high o/w partition coefficient diffuse passively others (moderately lipid soluble and partially ionised molecules) passes slowly.  Polar natural substance (sugar & amino acid) transported to brain actively thus structurally similar drug can pass easily to BBB.
  • 16.
  • 17. Only lipid soluble non ionised drugs penetrate easily to brain • e.g. volatile anaesthetics, ultra short acting barbiturates, narcotic analgesic, dopamine precursors and sympathomimetics Water soluble ionised drug fail to penetrate BBB. • e.g. dopamine, serotonine, streptomycin, quaternary substances
  • 18. 4. Blood CSF barrier  Mainly formed by choroid plexus of lateral, third & fourth ventricle.  The capillary endothelium that line choroid plexus have open junctions however the choroid cells are joined to each other by tight junctions.  Only highly lipid soluble, unionized drugs can pass through it.
  • 19. Blood cerebrospinal fluid barrier:  But CSF-brain barrier is not connected with tight junction.  Extremely permeable to drug molecule Clinical significance - Penicillin being less lipid soluble has poor penetration through BBB but if given by intrathecal route and thus cross CSF-brain barrier to treat the condition like brain abscess.
  • 20.  Maternal & fetal blood vessels are separated by a number of tissue layers made of fetal trophoblast , basement membrane & endothelium - placental barrier.  Drugs having molecular size less than 1000 D and moderate lipid solubility cross the placental barrier (Sulfonamides, Barbiturets, Steroids, Narcotic some Antibiotics ) . 5. Blood placental barrier
  • 21.  Transfer of substances - Passive diffusion – Non polar lipid soluble substances. Active transport - Amino acids and glucose. Pinocytosis - Maternal immunoglobulins.  Drugs that can cross Blood-Placental barrier. Ethanol, sulfonamides, barbiturates, gaseous anesthetics, steroids, narcotics, anticonvulsants etc.  Teratogen -Agent that causes toxic effect on fetus.  Teratogenicity – Fetal abnormality caused by administration of drugs during pregnancy.
  • 22.  Drug administered in last trimester affect vital functions of fetus.  Morphine - Fetal asphyxia  Antithyroid drugs - Neonatal goitre Hypoxia increase placental permeability for drugs.  Fetus to some extend is exposed to all drugs taken by mother hence drug administration should be severly restricted in pregnancy.
  • 23. 6. Blood testis barrier  Located at the sertoli- sertoli cell junction.  Tight junction between neighboring sertoli cells that act as barrier.  Restrict the passage of drugs to spermatocyte and spermatids.
  • 24. 2. Organ /tissue size &perfusion rate  Distribution is permeability related in following cases: 1. When the drug is ionic/polar/water soluble. 2. Where the highly selective physiology. barrier restrict the diffusion of such drugs to the inside of cell.  Distribution will be perfusion rate limited 1. When the drug is highly lipophilic. 2. When the membrane is highly permeable. 25  Perfusion rate - It is defined as the volume of the blood that flows per unit time per unit volume of the tissue. Unit : ml/min/ml  Highly perfused organs are - Lungs > Kidneys > Adrenals > Liver > Heart > Brain
  • 25.
  • 26. 3)Binding of drug to blood and other tissue components • Binding of drugs to blood components o Plasma proteins o Blood cells • Binding of drugs to extra vascular tissues • Human serum albumin:-all types of drugs. • ά1- acid glycoprotein: basic drugs like Imipramine. • Lipoproteins :-basic, lipophilic drugs(chlorpromazin). • ά1-Globuline :-steroids like corticosterone ,vit-B12. • ά2-Globuline :-vit-A,D,E,K,cupric ions. • Hemoglobin :-Phenytoin, phenothiazines. i) Plasma protein binding
  • 27. ii) Blood cells binding:- RBC : 40% of blood comprise of blood cells, out of that 95% cells are RBC.  The RBC comprises of 3 components each of which can bind to drugs:  Hemoglobin Carbonic Anhydrase  Cell Membrane  Drugs like, phenytoin, phenobarbiton binds with Hb.  Imipramine, chlorpromazine binds with RBC Cell wall
  • 28. B. Binding to Extra Vascular Tissue proteins: • 40% of total body weight comprise of vascular tissues • Tissue-drug binding result in localization of drug at specific site in body and serve as reservoir. • As binding increases it also increase bio-logical half life. • Irreversible binding leads to drug toxicity. (carbamazepin-autoinduction) • liver>kidney>lungs>muscle>skin>eye>bone>Hair, nail.
  • 29. 4). Miscellaneous Factors  Age a)Total body water b)Fat content c) Skeletal muscles d)Organ composition e) Plasma protein content  Pregnancy  Obesity  Diet  Disease states
  • 30. a)AGE:- Difference in distribution pattern is mainly due to Total body water -(both ICF &ECF) greater in infants Fat content - higher in infants & elderly  Skeletal muscle - lesser in infants & elderly organ composition – BBB is poorly developed in infants & myelin content is low & cerebral blood flow is high, hence greater penetration of drug in brain  plasma protein content- low albumin in both infants & elderly b) PREGNANCY:- During Pregnancy, due to growth of UTERUS,PLECENTA,FETUS… Increases the volume available for distribution drug.  fetus have separate compartment for drug distribution, plasma & ECF volume also increase but albumin content is low. C) OBESITY :-  In obese persons, high adipose (fatty acid) tissue so high distribution of lipophilic drugs.
  • 31. d) DIET:- A diet high in fats will increases free fatty acid levels in circulation thereby affecting binding of acidic drugs (NSAIDs to albumin). e) DISEASE STATES:- mechanism involved in alteration of drug distribution in disease states. i) Altered albumin & other drug-binding protein concentration. ii) Alteration or reduced perfusion to organ or tissue iii) Altered tissue pH. iv) Alteration of permeability of physiological barrier (BBB) Ex- BBB(in meningitis & encephalities) BBBbecomes more permeable polar antibiotics ampicilin, penicilin G. & patient affect CCF, Perfusion rate to entire body decreases it affect distribution. f) DRUG INTERACTION:-Displacement interaction occurs when two drugs administered which having similar binding site affinity. Ex. A.Warfarin (Displaced Drug)& B.Phenylbutabutazone (Displacer)HSA
  • 32. Apparent Volume of Distribution The apparent volume of distribution is a proportionality constant relating the plasma concentration to the total amount of drug in the body. XαC X=Vd.C Vd=X/C  Apparent volume of distribution is dependent on concentration of drug in plasma.  Drugs with a large apparent volume are more concentrated in extra vascular tissues and less concentrated intravascular. Vd = Total amount of drug (mg/kg) Concentration of drug in plasma (mg/l)